UMedic has prospective earnings growth over the next two years


UMediC Group Bhd's manufacturing plant in Batu Kawan, Penang.

PETALING JAYA: Rakuten Trade Sdn Bhd has placed a “buy” call on medical device maker UMediC Group Bhd with a higher target price (TP) of 90 sen from 76 sen.

In a report, the research house said the fast growing distributor of medical equipment and manufacturer of medical consumables is backed by solid prospective earnings growth over the next two years.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
UMedic

Next In Business News

Acwa pumping US$30bil in China to tap potential in renewables, green hydrogen
Iran war ceasefire Is positive for airlines, IATA’s Walsh says
Vietnam set for US$6bil inflows after securing long-awaited emerging market status
US bonds jump as Middle East ceasefire revives rate-cut bets
I-Bhd's i-City sees participation from Al Rajhi Bank
FBM KLCI climbs nearly 1% as Asian markets react to Middle East ceasefire
IATA chief says jet fuel supply could take months to recover after Hormuz reopening
Bank Muamalat offers temporary financial assistance to customers
CIMB offers payment relief to support customers affected by Middle East conflict
Oil slides below US$100, stocks soar as Trump agrees to two-week ceasefire

Others Also Read